
Product Description
Maribavir is an orally bioavailable benzimidazole L-riboside antiviral, with a spectrum of activity essentially limited to human cytomegalovirus (CMV) and Epstein–Barr virus (EBV). It is an inhibitor of the CMV UL97 kinase.
Maribavir is used to treat cytomegalovirus (CMV) infection or disease in adults and pediatric patients 12 years and older weighing at least 35 kg who have undergone transplantation and are resistant or refractory to conventional therapy (including ganciclovir, valganciclovir, cidofovir, or fomaliclovir).
Hits: 【Print】
Pre:Oseltamivir phosphate Next:LeterMovir